EGM
FATE icon

Engineers Gate Manager’s Fate Therapeutics FATE Stock Holding History

Engineers Gate Manager’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26,533
Closed -$43.8K – 2277
2024
Q4 		$43.8K Buy
+26,533
New +$66.9K ﹤0.01% 2103
2024
Q1 		– Sell
-46,847
Closed -$175K – 2026
2023
Q4 		$175K Buy
46,847
+31,460
+204% +$74.3K 0.01% 1672
2023
Q3 		$32.6K Sell
15,387
-23,193
-60% -$76.8K ﹤0.01% 1683
2023
Q2 		$184K Buy
+38,580
New +$213K 0.01% 1488
2023
Q1 		– Sell
-151,152
Closed -$1.53M – 1766
2022
Q4 		$1.53M Buy
151,152
+106,039
+235% +$1.99M 0.09% 278
2022
Q3 		$1.01M Buy
+45,113
New +$1.3M 0.06% 433
2022
Q2 		– Sell
-27,252
Closed -$1.06M – 2005
2022
Q1 		$1.06M Buy
+27,252
New +$1.06M 0.04% 623
2021
Q4 		– Sell
-20,482
Closed -$1.21M – 2090
2021
Q3 		$1.21M Buy
20,482
+5,008
+32% +$393K 0.07% 413
2021
Q2 		$1.34M Buy
15,474
+4,044
+35% +$326K 0.09% 312
2021
Q1 		$942K Buy
+11,430
New +$1.1M 0.05% 614
2020
Q4 		– Sell
-6,939
Closed -$277K – 1781
2020
Q3 		$277K Sell
6,939
-3,383
-33% -$118K 0.01% 1291
2020
Q2 		$354K Buy
+10,322
New +$308K 0.02% 1138
2019
Q4 		– Sell
-18,548
Closed -$288K – 1673
2019
Q3 		$288K Buy
18,548
+7,448
+67% +$143K 0.01% 1021
2019
Q2 		$225K Buy
+11,100
New +$200K 0.01% 952

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Engineers Gate Manager's FATE Position: Q1 2025 in Review

Engineers Gate Manager sold out of Fate Therapeutics (FATE) in Q1 2025, closing a stake of 26,533 shares — an estimated $43.8K sold.

Engineers Gate Manager first reported a position in FATE in Q2 2019 and held it in 14 quarters. The position peaked at $1.53M in Q4 2022. 132 funds tracked by Wall St. Rank hold FATE as of Q1 2025.

  • Engineers Gate Manager reported no remaining Fate Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 26,533 Fate Therapeutics shares in Q1 2025, an estimated $43.8K.
  • Engineers Gate Manager first reported a position in Fate Therapeutics in Q2 2019 and held it in 14 quarters.
  • Engineers Gate Manager's Fate Therapeutics position peaked at $1.53M in Q4 2022.
  • 132 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2025.

Based on Engineers Gate Manager's 13F filing for Q1 2025, filed 15 May 2025.